Search results for: Arne Risa Hole
Filter search results
OHE Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?
3 September 2018, 11:00pm
…is a widely held view – particularly in finance ministries and some sections of the media – that health systems such as the NHS are ‘black holes’, constantly demanding increased…
Understanding the preferences of people with acute leukemia for different health outcomes
25 September 2025
Share this: Download publication David Mott Hannah Hussain Sulayman Chowdhury Samantha Nier Chris Skedgel Key takeaways Pain and mobility are important, but its not the whole story. Patients and the…
The value of cell and gene therapies to the UK economy
20 October 2025
…data systems, regulation, and workforce skills. This report presents the first part of a whole-system economic framework designed to quantify the return on coordinated investment in cell and gene therapy. It considers…
Around the World in HTAs: United States – Making HTA Great Again
11 June 2024
…of HTA Today, HTA in the US reflects the health care system as a whole; it is characterised by a complex and decentralised landscape of public and private operators, including…
Invitation to OHE’s Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?
11 July 2018
…in finance ministries and some sections of the media – that health systems such as the NHS are ‘black holes’, constantly demanding increased funding without concomitant returns to society. The…
Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group
1 February 2007
Share this: Download publication Martina Garau Knowing the net value that companies, or whole sectors of the economy, bring is clearly important when considering economic and industrial policy. In this…
Novel devices: optimising drug delivery in multiple myeloma
9 December 2025
…myeloma and cancer as a whole. The notable shift from cytotoxic agents to targeted therapies has enabled subcutaneous (SC) administration as a practical alternative to intravenous (IV) infusion. There is…
Can a Strong Economic Case Be Made for Investing in the NHS?
1 January 2019
…holes’, constantly demanding increased funding without concomitant returns to society. In the 2018 OHE Annual Lecture, Professor Peter Smith argued that an economic case can be made for investment in…
Simon Brassel
4 March 2019
Simon Brassel is a Health Economist and Electrical Engineer with over ten years of professional experience in international healthcare markets. His expertise covers the whole spectrum of health technologies, from…